StockSelector.com
  Research, Select, & Monitor Tuesday, May 21, 2019 4:32:37 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Karyopharm Therapeutics Inc$5.23$.091.75%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Karyopharm Therapeutics Inc has an overall rank of 5081 out of 6850 stocks based on 10 positive rankings and 8 negative rankings.

Positive Rankings
PEGValue
Karyopharm Therapeutics Inc has a PEG Value of $164.55. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 3,101.40% in the next year. Among companies with a PEG Value above the current stock price, Karyopharm Therapeutics Inc is ranked 21.
Historic Revenue Growth
Karyopharm Therapeutics Inc rank is 35
Low vPut/Call
Karyopharm Therapeutics Inc has a low Put/Call ratio of 0.13 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Karyopharm Therapeutics Inc is ranked 226.
10 Day Gain
Karyopharm Therapeutics Inc rank is 442
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Karyopharm Therapeutics Inc is ranked 452.
Estimated Revenue Growth
Karyopharm Therapeutics Inc rank is 581
Target Prices
The average analysts' target price is $6.00 for Karyopharm Therapeutics Inc using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Karyopharm Therapeutics Inc is ranked 796.
Low Put/Call
Karyopharm Therapeutics Inc has a low Put/Call ratio of 0.44 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Karyopharm Therapeutics Inc is ranked 1074.
Debt-to-Equity
Karyopharm Therapeutics Inc rank is 1714
Price-to-Book
Karyopharm Therapeutics Inc rank is 2165
Negative Rankings
90 Day Loss
Karyopharm Therapeutics Inc rank is 183
Negative Net Margin
Karyopharm Therapeutics Inc rank is 247
Negative ROE
Karyopharm Therapeutics Inc rank is 369
Price-to-Sales
Karyopharm Therapeutics Inc rank is 493
Negative ROA
Karyopharm Therapeutics Inc rank is 496
Down EPS Surprise
Karyopharm Therapeutics Inc missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Cash Growth
Karyopharm Therapeutics Inc rank is 756
Down EPS Surprise
Karyopharm Therapeutics Inc missed the consensus earnings estimate when it last reported quarterly earnings.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.